New study tests nerve blocks to ease severe cancer pain
NCT ID NCT07653906
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two types of nerve blocks—coeliac plexus block and splanchnic nerve block—to see which one reduces pain better in adults with upper abdominal cancer. Forty-four participants will receive one of the procedures and be monitored for pain, opioid use, and quality of life over three months. The goal is to find a safer, more effective way to manage severe cancer pain.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- nerve block procedure (alcohol injection)
- What this could lead to
- If this works, it could offer a better way to manage severe cancer pain, reducing the need for strong painkillers and improving quality of life.
- What could go wrong
- This is a small, early-stage trial with only 44 participants. The results may not apply to everyone, and nerve blocks carry risks like bleeding or nerve damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABDOMINAL NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bangladesh Medical University
RECRUITINGDhaka, 1000, Bangladesh
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tape to tame Post-Surgery face swelling?
- Can AI-Guided home training boost recovery from gastric cancer surgery?
- Can patients safely dispense their own pain medicine after surgery?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can a new infusion drug shrink Hard-to-Treat tumors?
- Could a vaccine help fight Hard-to-Treat cancers?